XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 46.73

Change

+0.25 (+0.54)%

Market Cap

CAD 0.55B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-23 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.65 (+0.42%)

CAD 21.68B
ZSP:CA BMO S&P 500

+0.40 (+0.42%)

CAD 19.55B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.31 (+0.49%)

CAD 12.06B
VUN:CA Vanguard US Total Market

+0.41 (+0.35%)

CAD 11.46B
XUS:CA iShares Core S&P 500 Index ETF

+0.21 (+0.39%)

CAD 8.74B
HXS:CA Global X S&P 500 Corporate Cla..

+0.45 (+0.50%)

CAD 4.79B
VSP:CA Vanguard S&P 500 CAD hedged

+0.49 (+0.50%)

CAD 4.16B
XUU:CA iShares Core S&P US Total Mark..

+0.24 (+0.37%)

CAD 3.50B
QUU:CA Mackenzie US Large Cap Equity ..

+0.80 (+0.32%)

CAD 3.48B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.09 (+0.16%)

CAD 3.42B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.05% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.05% 72% C 72% C
Trailing 12 Months  
Capital Gain 33.51% 92% A 85% B
Dividend Return 1.06% 28% F 12% F
Total Return 34.57% 92% A 84% B
Trailing 5 Years  
Capital Gain 100.39% 77% C+ 86% B+
Dividend Return 6.69% 17% F 12% F
Total Return 107.08% 75% C 84% B
Average Annual (5 Year Horizon)  
Capital Gain 15.10% 78% C+ 79% B-
Dividend Return 15.96% 75% C 76% C+
Total Return 0.86% 27% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 15.59% 37% F 54% F
Risk Adjusted Return 102.39% 64% D 95% A
Market Capitalization 0.55B 53% F 60% D-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.